Company InVitro International Other OTC
Equities
IVRO
US4618531036
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
In-vitro (Non-animal) Consumer, Product, and Environmental Safety Test Method
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -7.13% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
65.2
%
| 1 | 73.0 % | 1 | 65.2 % | -16.97% |
Other Countries
34.8
%
| 0 | 27.0 % | 0 | 34.8 % | +19.41% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
W. Ulmer
CEO | Chief Executive Officer | - | 19-09-14 |
Cathy Richmond
DFI | Director of Finance/CFO | - | 19-09-14 |
Atul Jhalani
PSD | President | - | 19-06-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Irwin Gruverman
BRD | Director/Board Member | 89 | 20-09-22 |
Dennis Chenoweth
BRD | Director/Board Member | - | - |
W. Ulmer
CEO | Chief Executive Officer | - | 19-09-14 |
Cathy Richmond
DFI | Director of Finance/CFO | - | 19-09-14 |
Sean Adrean
BRD | Director/Board Member | - | - |
Steven Pitassi
BRD | Director/Board Member | - | 21-02-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,759,809 | 22,016,059 ( 96.73 %) | 0 | 96.73 % |
Company contact information
Invitro International
330 East Orangethorpe Avenue Suite D
92870, Placentia
+
http://www.invitrointl.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |